
    
      OUTLINE:

      Patients receive standard of care radium Ra 223 dichloride given by intravenous (IV) bolus
      every 4 weeks for up to 6 cycles. Patients undergo collection of blood every 1-3 months
      during radium Ra 223 dichloride treatment.

      After completion of study, patients are followed up every 3 months for up to 5 years from the
      date of treatment completion.
    
  